The Impact of Carbamylation and Anemia on HbA(1c)’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease

OBJECTIVE: Glycated hemoglobin (HbA(1c)) can predict risk for microvascular complications in patients with diabetes. However, HbA(1c)’s reliability in chronic kidney disease (CKD) has been questioned, with concerns including competition from another posttranslational protein modification, carbamylat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Mengyao, Berg, Anders, Rhee, Eugene P., Allegretti, Andrew S., Nigwekar, Sagar, Karumanchi, S. Ananth, Lash, James P., Kalim, Sahir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2023
Materias:
Epidemiology/Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797644/
https://www.ncbi.nlm.nih.gov/pubmed/36399777
http://dx.doi.org/10.2337/dc22-1399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797644/
https://www.ncbi.nlm.nih.gov/pubmed/36399777
http://dx.doi.org/10.2337/dc22-1399

Ejemplares similares